Cargando…

ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: A preliminary study

BACKGROUND: Early relapse in colorectal cancer (CRC) patients is attributed mainly to the higher malignant entity (such as an unfavorable genotype, deeper tumor invasion, lymph node metastasis and advance cancer stage) and poor response to chemotherapy. Several investigations have demonstrated that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Ming-Yii, Fang, Wei-Yu, Lee, Su-Chen, Cheng, Tian-Lu, Wang, Jaw-Yuan, Lin, Shiu-Ru
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2262891/ https://www.ncbi.nlm.nih.gov/pubmed/18267032 http://dx.doi.org/10.1186/1471-2407-8-50

Ejemplares similares

Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome
por: Huang, Ming-Yii, et al.
Publicado: (2013)

2251 Assessing research impact: It takes a team
por: Dunn, Ashley, et al.
Publicado: (2018)

ERCC1 Overexpression Increases Radioresistance in Colorectal Cancer Cells
por: Huang, Yi-Jung, et al.
Publicado: (2022)

Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population
por: Ni, Min, et al.
Publicado: (2014)

PReS-FINAL-2251: Influenza myositis outbreaks: clinical and laboratory findings
por: Cardin, SP, et al.
Publicado: (2013)

Cancer Stem Cell Gene Profile as Predictor of Relapse in High Risk Stage II and Stage III, Radically Resected Colon Cancer Patients
por: Giampieri, Riccardo, et al.
Publicado: (2013)

Correlation between immune signature and high‐density lipoprotein cholesterol level in stage II/III colorectal cancer
por: Wang, Yun, et al.
Publicado: (2019)

An explorative analysis of ERCC1-19q13 copy number aberrations in a chemonaive stage III colorectal cancer cohort
por: Smith, David Hersi, et al.
Publicado: (2013)

Prognostic significance of high triglyceride and apolipoprotein B levels in patients with stage III and high-risk stage II colorectal cancer undergoing curative surgery
por: Chen, Xiu-Qing, et al.
Publicado: (2020)

2251. Estimating the Need for Novel Gram-Negative Active Antibiotics in US Hospitals
por: Strich, Jeffrey R, et al.
Publicado: (2019)

Prognostic Factors Influencing Survival in Stage II and Stage III Colorectal Cancer Patients
por: Alkader, Mohammad S, et al.
Publicado: (2023)

High-dose concurrent chemo–proton therapy for Stage III NSCLC: preliminary results of a Phase II study
por: Oshiro, Yoshiko, et al.
Publicado: (2014)

PB2251: TWO POLYCYTHEMIA VERA PATIENTS WITH A DIAGNOSIS OF CONCOMITANT HEREDITARY HEMOCHROMATOSIS
por: Kiper Unal, H. D., et al.
Publicado: (2022)

Identification of 42 Genes Linked to Stage II Colorectal Cancer Metastatic Relapse
por: Al-Temaimi, Rabeah A., et al.
Publicado: (2016)

A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer
por: Chang, Yu-Tang, et al.
Publicado: (2016)

Identification and characterization of ANO9 in stage II and III colorectal carcinoma
por: Li, Chunxiang, et al.
Publicado: (2015)

Microsatellite instability & survival in patients with stage II/III colorectal carcinoma
por: Srdjan, Markovic, et al.
Publicado: (2016)

Nomogram for predicting overall survival in stage II‐III colorectal cancer
por: Liu, Jungang, et al.
Publicado: (2020)

Vitamin D Status and Survival in Stage II-III Colorectal Cancer
por: Bao, Yichao, et al.
Publicado: (2020)

High Expression of CUL9 Is Prognostic and Predictive for Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer
por: Zheng, Peng, et al.
Publicado: (2022)

ERCC overexpression associated with a poor response of cT4b colorectal cancer with FOLFOX-based neoadjuvant concurrent chemoradiation
por: Huang, Ming-Yii, et al.
Publicado: (2020)

2251. Comparing Statin Prescribing Rates in Eligible HIV vs. Non-HIV-Infected Patients
por: Blackman, Alison, et al.
Publicado: (2018)

2251. Evaluating the Financial Implications of Antimicrobial Therapy in Clinical Settings: A Prospective Observational Study
por: Gnanamani, James, et al.
Publicado: (2023)

Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer
por: Chen, Yuanyuan, et al.
Publicado: (2022)

Different clinicopathologic features and favorable outcomes of patients with stage III left-sided colon cancer
por: Huang, Ching-Wen, et al.
Publicado: (2015)

High-throughput proteomics profiling-derived signature associated with chemotherapy response and survival for stage II/III colorectal cancer
por: Ye, Shu-Biao, et al.
Publicado: (2023)

Cost‐effectiveness of adjuvant chemotherapy for high‐risk stage II and stage III colon cancer in South Africa
por: Tan, Sarah Xinhui, et al.
Publicado: (2023)

The Association of ERCC1 and ERCC5 Polymorphisms with Lung Cancer Risk in Han Chinese
por: Lan, Xueling, et al.
Publicado: (2022)

Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer
por: Posch, Florian, et al.
Publicado: (2017)

Association of Tumor-Infiltrating Lymphocytes With Survival in Stages II and III Colorectal Cancer
por: Vitorino, Marina, et al.
Publicado: (2022)

Analysis of ERCC1 and ERCC2 gene variants in osteosarcoma, colorectal and breast cancer
por: GÓMEZ-DÍAZ, BENJAMÍN, et al.
Publicado: (2015)

Stromal Expression of Vimentin Predicts the Clinical Outcome of Stage II Colorectal Cancer for High-Risk Patients
por: Liu, Li-guo, et al.
Publicado: (2017)

The CYP19 RS4646 Polymorphism IS Related to the Prognosis of Stage I–II and Operable Stage III Breast Cancer
por: Shao, Xiying, et al.
Publicado: (2015)

Duration of FOLFOX Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer With Deficient Mismatch Repair
por: Hu, Huabin, et al.
Publicado: (2020)

Association of ERCC1 rs3212986 & ERCC2 rs13181 polymorphisms with the risk of glioma
por: Cui, Qing-ke, et al.
Publicado: (2014)

Prognostic potential of ERCC1 protein expression and clinicopathologic factors in stage III/N(2) non-small cell lung cancer
por: Yan, Dong, et al.
Publicado: (2013)

Association of ERCC gene polymorphism with osteosarcoma risk
por: Wang, Guanliang, et al.
Publicado: (2020)

Survival nomograms for stage III colorectal cancer
por: Li, Chenglong, et al.
Publicado: (2018)

Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer
por: Sarasqueta, C., et al.
Publicado: (2019)

The value of adjuvant chemotherapy in stage II/III colorectal signet ring cell carcinoma
por: Zhao, Zhuang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gqipg94e0d2ke0gm27i2do9v6v